---
title: "Disease risk scores"
author: "Alexandros Rekkas"
institute: "Department of Medical Informatics, EMC"
date: "`r Sys.Date()`"
output:
  xaringan::moon_reader:
    lib_dir: libs
    nature:
      slideNumberFormat: ""
      highlightStyle: github
      highlightLines: true
      countIncrementalSlides: false
      ratio: 16:9
header-includes:
  - \newcommand\given[1][]{\:#1\vert\:}
  - \newcommand{\indep}{\perp \!\!\! \perp}
---

```{r xaringan-panelset, echo=FALSE, message=FALSE}
library(dagitty)
library(ggdag)
library(ggplot2)
library(knitr)
xaringanExtra::use_panelset()
options(htmltools.dir.version = FALSE, htmltools.preserve.raw = FALSE)
```

# Observational setting
```{r, cache=FALSE, echo=FALSE, warning=FALSE, fig.show="hold", out.width = '60%'}
include_graphics("figures/dag1.png")
```



---

# Propensity scores

.panelset[
.panel[.panel-name[Setting]
- $Y(0), Y(1)$: Potential outcomes
- $Y$: Observed outcome
- $Z$: Treatment
- $X$: Covariates

<br>

$$e(x) = P(Z = 1|X=x)$$

<br>

<br>

Conditioning on PS achieves "propensity balance"

\begin{equation}
Z\perp\!\!\!\perp X | e(x)
\end{equation}
]
.panel[.panel-name[Graph]
```{r, cache=FALSE, echo=FALSE, warning=FALSE, fig.show="hold", out.width = '50%'}
include_graphics("figures/dag2.png")
```
]
]



---

class: center middle
```{r, cache=FALSE, echo=FALSE, warning=FALSE, fig.show="hold", out.width = '60%'}
include_graphics("figures/dag3.png")
```


---

# Disease risk scores

<br>

<br>

$$r(x) = P(Y(0)=1|X=x)$$

<br>

<br>

Conditioning on DRS achieves "prognostic balance"
\begin{equation}
Y(0)\perp\!\!\!\perp X | r(x)
\end{equation}

<br>

> &#9964; **Assumption**: $Y(0)\perp\!\!\!\perp Z | X$ (_No unmeasured confounders_)


---


# Estimation of DRS

.panelset[
.panel[.panel-name[Setting]
Assume $Y(0)$ is binary

<br>

Estimate DRS from
$$r(x)=P(Y(0)=1|X=x) = g(\beta x),$$
where $g$ could be the inverse logit function

<br>

<br>

> &#9964; **Problem**: $Y(0)$ is not observed for everyone
]
.panel[.panel-name[Control arm]
- Fit the model only in the control arm patients for whom $Y(0)$ is observed
- Apply derived model on the treatment arm

<br>

**PROS**
- Accurate
- Small number of assumptions

<br>

**CONS**
- Can be overfitted to the control arm (rare outcomes -- early stages of new drug)
- Overestimates benefits in high risk patients -- Underestimates on lower risk patients
]
.panel[.panel-name[Both arms]
- Merge treatment and control arms
- Predict outcome from $P(Y=1|X=x, Z=z)=g(\beta x+\gamma z)$
- Derive patient DRS by setting $Z=0$ for everyone

<br>

**PROS**
- Larger sample size means more accurate estimates

<br>

**CONS**
- Strong model assumption -- Uniform treatment effect across categories of risk
]
]


---


# Evaluation

.panelset[
.panel[.panel-name[Propensity scores]
- Evaluate propensity balance

\begin{equation}
Z\perp\!\!\!\perp X | e(x)
\end{equation}

<br>

- Compare covariate distributions between treatment arms
]
.panel[.panel-name[Plot]
.center[
```{r, cache=FALSE, echo=FALSE, warning=FALSE, fig.show="hold", out.width = '44%'}
include_graphics("figures/balance.png")
```
]
]
]


---


# Evaluation DRS

- Evaluate prognostic balance

\begin{equation}
Y(0)\perp\!\!\!\perp X | r(x)
\end{equation}

<br>

- Compare covariate distributions between $\{Y(0)=1\}$ and $\{Y(0)=0\}$ patients

<br>

<br>

<br>

> &#9964; **Issue**: $Y(0)$ is not observed for everyone


---


# Evaluation DRS

.panelset[
.panel[.panel-name[Common]
- AUC
- Calibration metrics
- Goodness of fit metrics
]
.panel[.panel-name[Dry-run]
- Estimate propensity scores $\hat{e}(x)$ in the whole population and evaluate propensity balance
- Form _pseudo-.red[exposed]_ group by "flipping a coin" for each person in control group with probability $\hat{e}(x)$
- Form _pseudo-unexposed_ group using the control patients not in the pseudo-exposed group
- Model DRS in the pseudo-unexposed group
- Estimate treatment effect by matching on stratifying on the DRS
- Calculate "pseudo-bias" as the difference between estimated treatment effect and the _true_ null effect
- Repeat...
]
]


---


# Discussion

.panelset[
.panel[.panel-name[Advantages]
- Provides natural scale for the evaluation of treatment effect heterogeneity
- Stable over time. Allows for use of historic data
- More patients can be used in the analysis
- In settings with rare exposure estimation of PS is challenging. Not the case for DRS
- Less likely to be impacted by instrumental variables than PS
]
.panel[.panel-name[Disadvantages]
- Accurately modeling the DRS requires additional assumptions
- Not easily evaluated
- Not good with rare outcomes
- Effect estimates only generalizable to the treatment population
]
]
